Hydroxyzine HCl (NON-FORMULARY)
Disclaimer: Official controlled document is the CHEO online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.
- Adjunctive therapy in allergic conditions
- Management of anxiety
- Pre and post operative relief of anxiety
Reconstitution and Stability:
- Stable at room temperature
- Protect from light
- Use solutions within 15 minutes of mixing
- Solutions Compatible: DO NOT dilute
- Additives/Above Cassette Compatible: atropine sulphate, chlorpramazine, diphenhydramine, fentanyl, meperidine, midazolam, morphine sulphate, pentazocine lactate, promethazine HCl,
- Y-site Compatible: TPN (amino acids/dextrose)
- Incompatible: pentobarbital, phenobarbital
(For approved routes of administration by nursing personnel, refer to Policy for the Administration of Intravenous Medications.)
||YES, preferred mid-lateral muscles of the thigh
Usual dilution: undiluted
|IV Intermittent Infusion
|IV Continuous Infusion
(For neonatal dosages, refer to Neonatal IV Drug Manual.)
- 0.5-1 mg/kg/dose IM Q 4-6 hours PRN
- 25-100 mg/dose IM Q 4-6 hours PRN
Potential hazards of parenteral administration:
- Local discomfort, pain at the site of injection
- Drowsiness, dryness of the mouth, ataxia
- Urinary retention
- When used as a preoperative adjunctive medication, narcotic requirements may be reduced
- Use with caution in patients with narrow-angle glaucoma, asthma, COPD, bladder neck obstruction
The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.
CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.
Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.